What Researchers Did
Researchers reviewed preliminary studies on various alternative products and interventions for erectile dysfunction (ED).
What They Found
They found that alternative treatments for ED are gaining consumer interest and demonstrate varying degrees of efficacy in randomized trials and meta-analyses. While none are robust enough for first-line therapy, L-arginine shows growing evidence in combination with PDE5 inhibitors, and low-intensity shock wave and stem cell therapies demonstrate encouraging outcomes.
What This Means for Canadian Patients
Canadian patients interested in alternative ED treatments should discuss these options with their healthcare provider, as current evidence does not support them as first-line therapies. These treatments may be considered as complementary options or within research protocols, but their efficacy varies.
Canadian Relevance
This review does not have a direct Canadian connection, as it focuses on global literature regarding alternative ED treatments.
Study Limitations
A key limitation is that the reviewed alternative treatments lack robust evidence to be considered first-line therapy for erectile dysfunction.